CHOOLIP & SCIENCES Inc. (291650.KQ)
KOSDAQ · KRW · Healthcare · Biotechnology
₩2,385 (-0.63%) as of
Key statistics
- Market cap
- 72.79B
- Dividend yield
- 0.00%
- 52-week range
- 0.00 – 3,996.00
- Profit margin
- 0.00%
About CHOOLIP & SCIENCES Inc.
CHOOLIP & SCIENCES Inc., a bio venture company, focuses on the Aptamer technology platform for the development of therapeutic and diagnostic platforms. The company's platforms include aptamer discovery, optimization, and the development of therapeutics and diagnostics for cancer and neurological disorders. It offers AlloMAp and Bi-Functional Aptame (BiFAp) platform programs for therapeutics, as well as Aptodetect-lung, an early diagnosis kit for lung cancer. The company was formerly known as Aptamer Sciences Inc and changed its name to CHOOLIP & SCIENCES Inc. in August 2026. CHOOLIP & SCIENCES Inc. was founded in 2011 and is headquartered in Seongnam-si, South Korea.
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Seongnam-si, South Korea
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.